Deerfield, Illinois, Feb. 27, 2025 (GLOBE NEWSWIRE) -- DEERFIELD, IL. February 27, 2025 – Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

Drug developers are now frequently tasked with designing oral products for molecules with low solubility and low permeability ...

Hovione and Microinnova Engineering collaborate to advance modular flow chemistry for multi-purpose small molecule production: Lisbon, Portugal Friday, September 26, 2025, 13:00 H ...

According to a Comprehensive Research Report by Market Research Future (MRFR), “Active Pharmaceutical Ingredients Market Information by Manufacturing Process, Type of Synthesis, By API Formulation, ...

Inhaled drug formulation involves consideration of multiple factors, including the properties of the API, the needs of the target patient population, the delivery requirements, and the choice of ...

ANKLESHWAR, India--(BUSINESS WIRE)--RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...

Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on the Drug Master File (DMF-040171) with the U.S. Food and Drug Administration (FDA).

Mapi Pharma’s injectable version of cariprazine, developed using its patented Depot technology, has demonstrated a long-acting release profile, for one monthly injection. The product is designed to ...